🇺🇸 FDA
Patent

US 11059780

Substituted pyrrolidine compound and use thereof

granted A61KA61K31/40A61K31/4025

Quick answer

US patent 11059780 (Substituted pyrrolidine compound and use thereof) held by Takeda Pharmaceutical Company Limited expires Mon Jul 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Jul 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/40, A61K31/4025, A61K31/403, A61K31/4035